Aristada (Aripiprazole Lauroxil; Alkermes) Drug Outlook 2018-2026

May 23, 2018 | By - | Filed in: Press Releases.

Research and Markets LogoDUBLIN, May 23, 2018 /PRNewswire/ —
The “Drug Overview: Aristada” report has been added to’s offering.

Aristada (aripiprazole lauroxil; Alkermes) is a long-acting injectable formulation of the atypical antipsychotic aripiprazole.
It was developed…

To post and circulate your own press release on FIR and the eTN Network  please click here 


Comments are closed here.